Individuals with type 2 diabetes on metformin treatment had higher proglucagon levels, whereas insulin treatment lowered proglucagon to levels below the reference levels of individuals without diabetes (ESM Fig. 1). The gene discussed is INS; the disease is type 2 diabetes mellitus.